HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Pierre Hénichart Selected Research

Sphingosine N-Acyltransferase

6/2003Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Pierre Hénichart Research Topics

Disease

13Neoplasms (Cancer)
08/2014 - 06/2003
9Prostatic Neoplasms (Prostate Cancer)
03/2011 - 06/2003
2Carcinogenesis
01/2005 - 03/2003
1Leukemia
10/2011
1Poisoning
06/2008
1Pathologic Processes
01/2006
1Malaria
10/2005
1Colorectal Neoplasms (Colorectal Cancer)
01/2005
1Colonic Neoplasms (Colon Cancer)
01/2005

Drug/Important Bio-Agent (IBA)

5ErbB Receptors (EGF Receptor)IBA
03/2007 - 06/2003
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
03/2007 - 08/2003
3Gefitinib (Iressa)FDA Link
03/2007 - 02/2005
3Epidermal Growth Factor (EGF)IBA
08/2003 - 03/2003
2TubulinIBA
08/2014 - 10/2011
2phenstatinIBA
10/2011 - 08/2011
2Farnesyltranstransferase (Farnesyltransferase)IBA
03/2011 - 01/2005
2Hormones (Hormone)IBA
03/2011 - 03/2007
2DNA (Deoxyribonucleic Acid)IBA
06/2008 - 02/2004
2Tyrosine Kinase InhibitorsIBA
03/2007 - 02/2006
2Pharmaceutical PreparationsIBA
02/2006 - 01/2006
2Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2006 - 06/2003
2CeramidesIBA
08/2003 - 06/2003
2N-oleoylethanolamineIBA
08/2003 - 06/2003
2CeramidasesIBA
08/2003 - 06/2003
1Tubulin ModulatorsIBA
08/2011
11,4-diazepaneIBA
03/2011
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
02/2009
1EstersIBA
02/2009
1Protein Isoforms (Isoforms)IBA
02/2009
1IsoenzymesIBA
02/2009
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
08/2008
1Type I DNA Topoisomerases (Topoisomerase I)IBA
06/2008
1Type II DNA Topoisomerases (Topoisomerase II)IBA
06/2008
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
05/2006
1Cytotoxins (Cytolysins)IBA
02/2006
1cyclopamineIBA
02/2006
1p21(ras) farnesyl-protein transferase (protein farnesyltransferase)IBA
10/2005
1Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric
02/2005
1Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2005
1Nitric Oxide DonorsIBA
02/2005
1Arachidonic Acid (Vitamin F)IBA
12/2004
1EnzymesIBA
12/2004
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
12/2004
1LipoxygenasesIBA
12/2004
1QuinazolinesIBA
02/2004
1CamptothecinIBA
02/2004
1AlkaloidsIBA
02/2004
1QuinolinesIBA
02/2004
1adenosine-3',5'-cyclic phosphorothioateIBA
08/2003
1CaspasesIBA
08/2003
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
08/2003
14- ((3- bromophenyl)amino)- 6,7- dimethoxyquinazolineIBA
08/2003
1fumonisin B1IBA
06/2003
1anandamide (arachidonylethanolamide)IBA
06/2003
1LipidsIBA
06/2003
1Coloring Agents (Dyes)IBA
06/2003
1LigandsIBA
06/2003
1CannabinoidsIBA
06/2003
1Sphingosine N-AcyltransferaseIBA
06/2003
1Trypan BlueFDA Link
06/2003

Therapy/Procedure

3Therapeutics
12/2005 - 03/2003
1Drug Therapy (Chemotherapy)
12/2004